Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Postoperative anemia is common in cardiac surgery with cardiopulmonary bypass. Iron
deficiency delays the recovery from postoperative anemia and may negatively affect the
postoperative trajectory of cardiac surgery patients. The objective of the study is to
determine the effect of treatment of postoperative iron deficiency anemia with intravenous
iron on disability 90 days after surgery. This will be evaluated in a randomized
placebo-controlled double blind two-center trial in which 310 elective cardiac surgery
patients will be included.